Torthaí cuardaigh - Katy Wilson
- 1 - 3 toradh as 3 á dtaispeáint
-
1
Systematic review and network meta-analysis comparing ocrelizumab with other treatments for relapsing multiple sclerosis de réir Rachael McCool, Katy Wilson, Mick Arber, Kelly Fleetwood, Sydney Toupin, Howard Thom, Iain Bennett, Susan Edwards
Foilsithe / Cruthaithe 2019Revisão -
2
Risk factors for carbapenem-resistant Gram-negative bacterial infections: a systematic review de réir Zaira R. Palacios‐Baena, Maddalena Giannella, Davide Manissero, Jesús Rodríguez‐Baño, Pierluigi Viale, Sara Lopes, Katy Wilson, Rachael McCool, Christopher Longshaw
Foilsithe / Cruthaithe 2020Revisão -
3
Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel Warhead de réir N. G. R. Dayan Elshan, Karen C. Wolff, Laura Riva, Ashley K. Woods, Gennadii A. Grabovyi, Katy Wilson, James Pedroarena, Sourav Ghorai, Armen Nazarian, Frank Ulrich Weiß, Yuyin Liu, Wrickban Mazumdar, Lirui Song, Neechi Okwor, Jacqueline Malvin, Malina A. Bakowski, Nathan Beutler, Melanie G. Kirkpatrick, Amal Gebara-Lamb, Edward Huang, Vân Nguyên-Trân, Victor Chi, Shuangwei Li, Thomas F. Rogers, Case W. McNamara, Anil K. Gupta, Alireza Rahimi, Jian Jeffrey Chen, Sean B. Joseph, Peter G. Schultz, Arnab K. Chatterjee
Foilsithe / Cruthaithe 2024Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Medicine
Biochemistry
Biology
Internal medicine
Alternative medicine
Antibiotics
Antiretroviral therapy
Antiviral drug
Biotechnology
Carbapenem
Chemistry
Cochrane Library
Drug
Enzyme
Furin
Immunology
In vitro
In vivo
Intensive care medicine
Intensive care unit
Lymphoma
MEDLINE
Mechanical ventilation
Microbiology
Multiple sclerosis
Ocrelizumab
Pathology
Pharmacology
Placebo
Potency